These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2831348)

  • 1. Reduction of experimental canine myocardial infarct size with prostaglandin E1: inhibition of neutrophil migration and activation.
    Simpson PJ; Mickelson J; Fantone JC; Gallagher KP; Lucchesi BR
    J Pharmacol Exp Ther; 1988 Feb; 244(2):619-24. PubMed ID: 2831348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of serotonin (5HT2) receptor blockade in myocardial reperfusion injury: effects of LY53857 in a canine model of myocardial infarction.
    Simpson PJ; Schelm JA; Jakubowski JA; Smallwood JK
    J Pharmacol Exp Ther; 1991 Sep; 258(3):979-85. PubMed ID: 1653847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart.
    Simpson PJ; Mickelson J; Fantone JC; Gallagher KP; Lucchesi BR
    Circ Res; 1987 May; 60(5):666-73. PubMed ID: 2439229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood cardioplegia supplementation with the sodium-hydrogen ion exchange inhibitor cariporide to attenuate infarct size and coronary artery endothelial dysfunction after severe regional ischemia in a canine model.
    Muraki S; Morris CD; Budde JM; Zhao ZQ; Guyton RA; Vinten-Johansen J
    J Thorac Cardiovasc Surg; 2003 Jan; 125(1):155-64. PubMed ID: 12538999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog.
    Mizumura T; Nithipatikom K; Gross GJ
    Cardiovasc Res; 1995 Apr; 29(4):482-9. PubMed ID: 7796441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence.
    Jordan JE; Zhao ZQ; Sato H; Taft S; Vinten-Johansen J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):301-9. PubMed ID: 8996210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infarct salvage with liposomal prostaglandin E1 administered by intravenous bolus immediately before reperfusion in a canine infarction-reperfusion model.
    Smalling RW; Feld S; Ramanna N; Amirian J; Felli P; Vaughn WK; Swenson C; Janoff A
    Circulation; 1995 Aug; 92(4):935-43. PubMed ID: 7641377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clentiazem given at reperfusion improves subendocardial reflow and reduces myocardial infarct size in the dog.
    Rousseau G; Provost P; Tran D; Caillé G; Latour JG
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1252-60. PubMed ID: 8138938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human complement C5a receptor antagonist reduces infarct size after surgical revascularization.
    Riley RD; Sato H; Zhao ZQ; Thourani VH; Jordan JE; Fernandez AX; Ma XL; Hite DR; Rigel DF; Pellas TC; Peppard J; Bill KA; Lappe RW; Vinten-Johansen J
    J Thorac Cardiovasc Surg; 2000 Aug; 120(2):350-8. PubMed ID: 10917953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of canine infarct size by bolus intravenous administration of liposomal prostaglandin E1: comparison with control, placebo liposomes, and continuous intravenous infusion of prostaglandin E1.
    Feld S; Li G; Wu A; Felli P; Amirian J; Vaughn WK; Gornet T; Swenson C; Smalling RW
    Am Heart J; 1996 Oct; 132(4):747-57. PubMed ID: 8831361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term inhibition of myocardial infarction by postconditioning during reperfusion.
    Mykytenko J; Kerendi F; Reeves JG; Kin H; Zatta AJ; Jiang R; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Basic Res Cardiol; 2007 Jan; 102(1):90-100. PubMed ID: 17003965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits.
    Onogi H; Minatoguchi S; Chen XH; Bao N; Kobayashi H; Misao Y; Yasuda S; Yamaki T; Maruyama R; Uno Y; Arai M; Takemura G; Fujiwara H
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1035-41. PubMed ID: 17042911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitation of myocardial infarct size in pigs with a dual lipoxygenase-cyclooxygenase blocking agent by inhibition of neutrophil activity without reduction of neutrophil migration.
    Amsterdam EA; Pan HL; Rendig SV; Symons JD; Fletcher MP; Longhurst JC
    J Am Coll Cardiol; 1993 Nov; 22(6):1738-44. PubMed ID: 8227848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deferoxamine pretreatment reduces canine infarct size and oxidative injury.
    Lesnefsky EJ; Repine JE; Horwitz LD
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1103-9. PubMed ID: 2359019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion.
    Liu X; Huang Y; Pokreisz P; Vermeersch P; Marsboom G; Swinnen M; Verbeken E; Santos J; Pellens M; Gillijns H; Van de Werf F; Bloch KD; Janssens S
    J Am Coll Cardiol; 2007 Aug; 50(8):808-17. PubMed ID: 17707188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of heart rate reduction by 4-(N-ethyl-N-phenyl-amino)-1,2-dimethyl-6-(methylamino)pyrimidinium chloride on infarct size in dog.
    Schlack W; Ebel D; Grunert S; Halilović S; Meyer O; Thämer V
    Arzneimittelforschung; 1998 Jan; 48(1):26-33. PubMed ID: 9522027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the platelet-activating factor antagonist RP 59227 (Tulopafant) on myocardial ischemia/reperfusion injury and neutrophil function.
    Auchampach JA; Pieper GM; Cavero I; Gross GJ
    Basic Res Cardiol; 1998 Oct; 93(5):361-71. PubMed ID: 9833148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning.
    Halkos ME; Kerendi F; Corvera JS; Wang NP; Kin H; Payne CS; Sun HY; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Ann Thorac Surg; 2004 Sep; 78(3):961-9; discussion 969. PubMed ID: 15337028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic defibrination with ancrod does not protect canine myocardium from reperfusion injury.
    Simpson PJ; Schelm JA; Smith GF
    J Pharmacol Exp Ther; 1991 Feb; 256(2):780-6. PubMed ID: 1704437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion.
    Zhao ZQ; Nakamura M; Wang NP; Velez DA; Hewan-Lowe KO; Guyton RA; Vinten-Johansen J
    J Surg Res; 2000 Dec; 94(2):133-44. PubMed ID: 11104653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.